NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE:BMY) will take part in Leerink Partners Immuno-Oncology Roundtable on Thursday, October 1, 2015, in New York. Michael Giordano, senior vice president, Head of Development, Oncology, will answer questions about the company at 10 a.m. EDT.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150924006353/en/

Source: Bristol-Myers Squibb Company